Try the Demo today!
| SEC Filing | Insider | Company | Trade Date | Transaction | Shares | Avg. Price | Total | % Holdings | Return |
|---|---|---|---|---|---|---|---|---|---|
| 29-Jan-10 12:46 PM View:  | Evnin Luke Director 10% Owner | Metabasis Therapeutics Inc. (MBRX) | 27-Jan-10 | Disposition Duplicate | 4,814,720 | -- | -- | (100%) 4.81M to 0 | |
| 29-Jan-10 12:39 PM View: | Mpm Bioventures II Qp Lp 10% Owner | Metabasis Therapeutics Inc. (MBRX) | 27-Jan-10 | Disposition | 4,814,720 | -- | -- | (100%) 4.81M to 0 | |
| 19-Nov-08 7:43 PM View: | Laikind Paul K Chief Executive Officer | Metabasis Therapeutics Inc. (MBRX) | 19-Nov-08 | Market Purchase | 4,700 | $0.66 | $3,123.84 | < 1% 702.52K to 707.22K | 12% |
| 19-Nov-08 7:43 PM View: | Laikind Paul K Chief Executive Officer | Metabasis Therapeutics Inc. (MBRX) | 18-Nov-08 | Market Purchase | 1,300 | $0.54 | $704.00 | < 1% 701.22K to 702.52K | 38% |
| 18-Apr-08 2:58 PM View: | Oronsky Arnold L Director 10% Owner | Metabasis Therapeutics Inc. (MBRX) | 16-Apr-08 | Market Purchase | 990,816 | $2.34 | $2,318,510.00 | 38% 2.63M to 3.62M | (68%) |
| 18-Apr-08 2:27 PM View: | Mpm Bioventures II Qp Lp 10% Owner | Metabasis Therapeutics Inc. (MBRX) | 16-Apr-08 | Market Purchase Duplicate | 71,866 | $2.34 | $168,166.00 | < 1% 9.24M to 9.31M | (68%) |
| 18-Apr-08 2:04 PM View: | Interwest Partners Vii L P 10% Owner | Metabasis Therapeutics Inc. (MBRX) | 16-Apr-08 | Market Purchase | 945,577 | $2.34 | $2,212,650.00 | 35% 2.68M to 3.63M | (68%) |
| 18-Apr-08 2:04 PM View: | Interwest Partners Vii L P 10% Owner | Metabasis Therapeutics Inc. (MBRX) | 16-Apr-08 | Exercise (in-the money or at-the-money) | 12,511 | $2.34 | $29,275.70 | < 1% 3.93M to 3.95M | (68%) |
| 18-Apr-08 2:27 PM View: | Evnin Luke Director 10% Owner | Metabasis Therapeutics Inc. (MBRX) | 16-Apr-08 | Market Purchase | 71,866 | $2.34 | $168,166.00 | < 1% 9.24M to 9.31M | (68%) |
| 18-Apr-08 2:58 PM View: | Oronsky Arnold L Director 10% Owner | Metabasis Therapeutics Inc. (MBRX) | 16-Apr-08 | Exercise (in-the money or at-the-money) | 273,763 | $2.34 | $640,605.00 | 8% 3.62M to 3.9M | (68%) |
| 18-Apr-08 2:27 PM View: | Mpm Bioventures II Qp Lp 10% Owner | Metabasis Therapeutics Inc. (MBRX) | 16-Apr-08 | Exercise (in-the money or at-the-money) Duplicate | 244,881 | $2.34 | $573,022.00 | 3% 9.31M to 9.56M | (68%) |
| 17-Apr-08 7:13 PM View: | Hale David F Director | Metabasis Therapeutics Inc. (MBRX) | 16-Apr-08 | Market Purchase | 10,000 | $2.34 | $23,400.00 | 21% 47.23K to 57.23K | (68%) |
| 18-Apr-08 2:04 PM View: | Interwest Partners Vii L P 10% Owner | Metabasis Therapeutics Inc. (MBRX) | 16-Apr-08 | Market Purchase | 45,239 | $2.34 | $105,859.00 | 1% 3.63M to 3.67M | (68%) |
| 18-Apr-08 2:27 PM View: | Evnin Luke Director 10% Owner | Metabasis Therapeutics Inc. (MBRX) | 16-Apr-08 | Exercise (in-the money or at-the-money) | 244,881 | $2.34 | $573,022.00 | 3% 9.31M to 9.56M | (68%) |
| 18-Apr-08 6:06 PM View: | Credit Suisse First Boston/ 10% Owner | Metabasis Therapeutics Inc. (MBRX) | 16-Apr-08 | Exercise (out-of-the-money) | 119,454 | -- | -- | 3% 3.55M to 3.67M | |
| 18-Apr-08 6:06 PM View: | Credit Suisse First Boston/ 10% Owner | Metabasis Therapeutics Inc. (MBRX) | 16-Apr-08 | Market Purchase | 196,633 | $2.34 | $460,121.00 | 5% 3.67M to 3.86M | (68%) |
| 17-Apr-08 7:13 PM View: | Hale David F Director | Metabasis Therapeutics Inc. (MBRX) | 16-Apr-08 | Exercise (in-the money or at-the-money) | 3,111 | $2.34 | $7,279.74 | 5% 57.23K to 60.34K | (68%) |
| 18-Apr-08 2:04 PM View: | Interwest Partners Vii L P 10% Owner | Metabasis Therapeutics Inc. (MBRX) | 16-Apr-08 | Exercise (in-the money or at-the-money) | 261,252 | $2.34 | $611,330.00 | 7% 3.67M to 3.93M | (68%) |
| 21-Jun-07 12:40 PM View: | Beck John W Chief Financial Officer | Metabasis Therapeutics Inc. (MBRX) | 19-Jun-07 | Market Sale (Planned) | 3,400 | $8.07 | $27,446.30 | (1%) 239.63K to 236.23K | 91% |
| 05-Jun-07 2:48 PM View: | Beck John W Chief Financial Officer | Metabasis Therapeutics Inc. (MBRX) | 01-Jun-07 | Market Sale (Planned) | 10,035 | $8.00 | $80,284.00 | (4%) 250.07K to 240.03K | 91% |
| 24-May-07 4:02 PM View: | Beck John W Chief Financial Officer | Metabasis Therapeutics Inc. (MBRX) | 22-May-07 | Market Sale (Planned) | 300 | $8.00 | $2,400.00 | (< 1%) 249.97K to 249.67K | 91% |
| 25-Apr-07 7:51 PM View: | Beck John W Chief Financial Officer | Metabasis Therapeutics Inc. (MBRX) | 25-Apr-07 | Market Sale (Planned) | 3,300 | $8.13 | $26,829.00 | (1%) 253.27K to 249.97K | 91% |
| 25-Apr-07 7:50 PM View: | Baracchini Edgardo Jr Sr. VP of Business Development | Metabasis Therapeutics Inc. (MBRX) | 24-Apr-07 | Market Sale (Planned) | 4,300 | $8.21 | $35,282.00 | (11%) 40.83K to 36.53K | 91% |
| 10-Apr-07 3:03 PM View: | Beck John W Chief Financial Officer | Metabasis Therapeutics Inc. (MBRX) | 10-Apr-07 | Market Sale (Planned) | 6,172 | $8.00 | $49,376.00 | (2%) 275.65K to 269.48K | 91% |
| 10-Apr-07 3:03 PM View: | Beck John W Chief Financial Officer | Metabasis Therapeutics Inc. (MBRX) | 09-Apr-07 | Market Sale (Planned) | 1,828 | $8.00 | $14,624.00 | (< 1%) 277.48K to 275.65K | 91% |
| 27-Feb-07 1:39 PM View: | Beck John W Chief Financial Officer | Metabasis Therapeutics Inc. (MBRX) | 26-Feb-07 | Market Sale | 3,300 | $8.00 | $26,400.00 | (1%) 265.57K to 262.27K | 91% |
| 28-Feb-07 4:47 PM View: | Baracchini Edgardo Jr Sr. VP of Business Development | Metabasis Therapeutics Inc. (MBRX) | 26-Feb-07 | Market Sale (Planned) | 700 | $8.00 | $5,600.00 | (2%) 41.53K to 40.83K | 91% |
| 05-Dec-06 2:21 PM View: | Beck John W Chief Financial Officer | Metabasis Therapeutics Inc. (MBRX) | 05-Dec-06 | Market Sale (Planned) | 9,000 | $8.00 | $72,000.00 | (3%) 272.13K to 263.13K | 91% |
| 29-Nov-06 3:24 PM View: | Beck John W CFO | Metabasis Therapeutics Inc. (MBRX) | 27-Nov-06 | Market Sale (Planned) | 500 | $8.01 | $4,006.00 | (< 1%) 272.63K to 272.13K | 91% |
| 13-Nov-06 2:03 PM View: | Beck John W Sr. VP, Finance & CFO | Metabasis Therapeutics Inc. (MBRX) | 08-Nov-06 | Market Sale (Planned) | 9,000 | $8.00 | $72,000.00 | (3%) 281.63K to 272.63K | 91% |
| 07-Nov-06 4:45 PM View: | Credit Suisse First Boston/ 10% Owner | Metabasis Therapeutics Inc. (MBRX) | 03-Nov-06 | Market Purchase | 527,000 | $7.17 | $3,776,320.00 | 17% 3.02M to 3.55M | (90%) |
| 11-Sep-06 5:50 PM View: | Laikind Paul K President, CEO & Secretary Director | Metabasis Therapeutics Inc. (MBRX) | 31-Aug-06 | Gift | 16,800 | -- | -- | (2%) 714.36K to 697.56K | |
| 28-Jun-06 9:26 PM View: | Baracchini Edgardo Jr Sr. VP, Business Development | Metabasis Therapeutics Inc. (MBRX) | 26-Jun-06 | Market Sale (Planned) | 500 | $8.35 | $4,175.00 | (1%) 37.03K to 36.53K | 91% |
| 08-Jun-06 10:00 PM View: | Gschwend Heinz W Director | Metabasis Therapeutics Inc. (MBRX) | 07-Jun-06 | Option Exercise | 11,864 | $2.46 | $29,221.40 | 32% 36.81K to 48.68K | |
| 24-May-06 2:58 PM View: | Cash Harvey B 10% Owner | Metabasis Therapeutics Inc. (MBRX) | 22-May-06 | Market Purchase | 39,836 | $8.02 | $319,648.00 | 392% 10.16K to 50.0K | (91%) |
| 24-May-06 2:58 PM View: | Cash Harvey B 10% Owner | Metabasis Therapeutics Inc. (MBRX) | 19-May-06 | Market Purchase | 5,000 | $8.10 | $40,500.00 | 97% 5.16K to 10.16K | (91%) |
| 24-May-06 2:58 PM View: | Cash Harvey B 10% Owner | Metabasis Therapeutics Inc. (MBRX) | 18-May-06 | Market Purchase | 700 | $8.10 | $5,670.00 | 16% 4.46K to 5.16K | (91%) |
| 24-May-06 2:58 PM View: | Cash Harvey B 10% Owner | Metabasis Therapeutics Inc. (MBRX) | 16-May-06 | Market Purchase | 4,464 | $8.00 | $35,706.20 | 100% 0 to 4.46K | (91%) |
| 09-Mar-07 3:24 PM View: | Beck John W Chief Financial Officer | Metabasis Therapeutics Inc. (MBRX) | 01-Mar-06 | Sale (Planned) | 1,000 | $8.00 | $8,000.00 | (< 1%) 262.27K to 261.27K | |
| 04-Oct-05 4:09 PM View: | Credit Suisse First Boston/ 10% Owner | Metabasis Therapeutics Inc. (MBRX) | 30-Sep-05 | Market Purchase | 341,297 | $5.86 | $2,000,000.00 | 21% 1.65M to 1.99M | (87%) |
| 04-Oct-05 6:15 PM View: | Evnin Luke Director 10% Owner | Metabasis Therapeutics Inc. (MBRX) | 30-Sep-05 | Market Purchase Duplicate | 699,659 | $5.86 | $4,100,000.00 | (13%) 5.2M to 4.5M | 87% |
| 04-Oct-05 8:15 PM View: | Interwest Partners Vii L P 10% Owner | Metabasis Therapeutics Inc. (MBRX) | 30-Sep-05 | Market Purchase | 407,124 | $5.86 | $2,385,750.00 | 18% 2.2M to 2.61M | (87%) |
| 04-Oct-05 3:19 PM View: | Oronsky Arnold L Director 10% Owner | Metabasis Therapeutics Inc. (MBRX) | 30-Sep-05 | Market Purchase | 426,621 | $5.86 | $2,500,000.00 | 19% 2.2M to 2.63M | (87%) |
| 04-Oct-05 6:12 PM View: | Mpm Bioventures II Qp Lp 10% Owner | Metabasis Therapeutics Inc. (MBRX) | 30-Sep-05 | Market Purchase | 699,659 | $5.86 | $4,100,000.00 | (13%) 5.2M to 4.5M | 87% |
| 04-Oct-05 8:15 PM View: | Interwest Partners Vii L P 10% Owner | Metabasis Therapeutics Inc. (MBRX) | 30-Sep-05 | Market Purchase | 19,497 | $5.86 | $114,252.00 | < 1% 2.61M to 2.63M | (87%) |
| 04-Nov-05 4:01 PM View: | Gschwend Heinz W Director | Metabasis Therapeutics Inc. (MBRX) | 07-Sep-05 | Market Purchase | 2,000 | $4.00 | $8,000.00 | 6% 34.81K to 36.81K | (81%) |
| 04-Nov-05 4:01 PM View: | Gschwend Heinz W Director | Metabasis Therapeutics Inc. (MBRX) | 22-Aug-05 | Market Purchase | 3,000 | $4.36 | $13,080.00 | 9% 31.81K to 34.81K | (83%) |
| 11-Aug-05 9:34 PM View: | Gschwend Heinz W Director | Metabasis Therapeutics Inc. (MBRX) | 09-Aug-05 | Option Exercise | 4,354 | $2.65 | $11,538.10 | 37% 11.63K to 15.98K | |
| 11-Apr-05 3:37 PM View: | Sicor Inc 10% Owner | Metabasis Therapeutics Inc. (MBRX) | 08-Apr-05 | Acquisition (other) | 117,043 | -- | -- | 6% 2.11M to 2.23M | |
| 24-Jan-05 5:18 PM View: | Oronsky Arnold L Director 10% Owner | Metabasis Therapeutics Inc. (MBRX) | 03-Jan-05 | Gift | 500 | -- | -- | (100%) 0.5K to 0 |
